Inositol Supplementation and Body Mass Index: A Systematic Review and Meta-analysis of Randomized Clinical Trials

Overview

Journal Obes Sci Pract

Date 2022 Jun 6

PMID 35664247

Authors

Meysam Zarezadeh

Azadeh Dehghani

Amir Hossein Faghfouri

Nima Radkhah

Mohammad Naemi Kermanshahi

Fatemeh Hamedi Kalajahi

Niyaz Mohammadzadeh Honarvar

Zohreh Ghoreishi

Alireza Ostadrahimi

Mehrangiz Ebrahimi Mamaghani

Affiliations

Soon will be listed here.

Abstract

Background: Inositol is a sugar-alcohol and recognized as a key component of cell membrane phospholipids. It has crucial role in the cell signaling pathways and contribute to improving glycemic responses. Although some earlier studies have revealed the effect of inositol mediating glucose uptake by improving insulin sensitivity, the benefit of inositol supplementation in patients with overweight and obesity is not completely understood. This study aimed to assess the impact of inositol supplementation on body mass index (BMI) through a systematic review and meta-analysis of controlled clinical trials.

Methods: A systematic search was performed to August 2021 in the following databases: PubMed-Medline, Embase, Web of Science and Scopus. Fifteen controlled clinical trials investigating the effect of inositol on adult's BMI were finally included in the study. A random-effects model was employed to estimate the effect size. Subgroup analysis was performed by dose, duration, age, type of inositol. Meta-regression was used to investigate presence of any linear relationship. Begg's and Egger's tests were carried out to detect small study effect.

Results: The results of pooled analysis showed that inositol supplementation significantly decreased BMI scores (WMD = -0.41 kg/m; 95% CI: -0.78, -0.04; = 0.028). Subgroup analysis was performed to identify the source of heterogeneity among studies ( = 73.9%, < 0.001), demonstrating supplementation duration, baseline BMI, mean age of participants, type of inositol and dosage were potential sources of heterogeneity. The effect of intervention was more clinically significant in participants with polycystic ovary syndrome (PCOS) and overweight/obesity. Inositol in the form of myo-inositol (MI) had stronger effect on BMI reduction.

Conclusion: The meta-analysis suggests that oral inositol supplementation has positive effect on BMI reduction. Inositol supplementation could be considered as an adjunct treatment to improve body mass index.

Citing Articles

Urinary Metabolite Profiles of Participants with Overweight and Obesity Prescribed a Weight Loss High Fruit and Vegetable Diet: A Single Arm Intervention Study.

Clarke E, Gomez-Martin M, Stanford J, Yilmaz A, Ustun I, Wood L Nutrients. 2025; 16(24.

PMID: 39770979 PMC: 11677377. DOI: 10.3390/nu16244358.

The effect of Myo-inositol on improving sperm quality and IVF outcomes: A systematic review and meta-analysis.

Ghaemi M, Seighali N, Shafiee A, Beiky M, Kohandel Gargari O, Azarboo A Food Sci Nutr. 2024; 12(11):8515-8524.

PMID: 39619962 PMC: 11606893. DOI: 10.1002/fsn3.4427.

Exploring the therapeutic mechanisms of millet in obesity through molecular docking, pharmacokinetics, and dynamic simulation.

Lakhani K, Hamid R, Gupta S, Prajapati P, Prabha R, Patel S Front Nutr. 2024; 11:1453819.

PMID: 39494311 PMC: 11528469. DOI: 10.3389/fnut.2024.1453819.

Carob () Flour as Source of Bioactive Compounds: Production, Characterization and Nutraceutical Value.

Benito-Vazquez I, Garrido-Romero M, Hontoria-Caballo G, Garcia-Garcia C, Diez-Municio M, Moreno F Foods. 2024; 13(19).

PMID: 39410059 PMC: 11475722. DOI: 10.3390/foods13193024.

<sc>d</sc>-Chiro-Inositol in Clinical Practice: A Perspective from the Experts Group on Inositol in Basic and Clinical Research (EGOI).

Dinicola S, Unfer V, Soulage C, Yap-Garcia M, Bevilacqua A, Benvenga S Gynecol Obstet Invest. 2024; 89(4):284-294.

PMID: 38373412 PMC: 11309080. DOI: 10.1159/000536081.

References

Dinicola S, Minini M, Unfer V, Verna R, Cucina A, Bizzarri M . Nutritional and Acquired Deficiencies in Inositol Bioavailability. Correlations with Metabolic Disorders. Int J Mol Sci. 2017; 18(10). PMC: 5666868. DOI: 10.3390/ijms18102187. View

Tabrizi R, Ostadmohammadi V, Lankarani K, Peymani P, Akbari M, Kolahdooz F . The effects of inositol supplementation on lipid profiles among patients with metabolic diseases: a systematic review and meta-analysis of randomized controlled trials. Lipids Health Dis. 2018; 17(1):123. PMC: 5968598. DOI: 10.1186/s12944-018-0779-4. View

Scioscia M, Kunjara S, Gumaa K, Galan A, McLean P, Rodeck C . Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol Obstet Invest. 2007; 64(4):217-23. DOI: 10.1159/000106494. View

Costantino D, Minozzi G, Minozzi E, Guaraldi C . Metabolic and hormonal effects of myo-inositol in women with polycystic ovary syndrome: a double-blind trial. Eur Rev Med Pharmacol Sci. 2009; 13(2):105-10. View

Yao Y, Shan F, Bian J, Chen F, Wang M, Ren G . D-chiro-inositol-enriched tartary buckwheat bran extract lowers the blood glucose level in KK-Ay mice. J Agric Food Chem. 2008; 56(21):10027-31. DOI: 10.1021/jf801879m. View

Santamaria A, Giordano D, Corrado F, Pintaudi B, Interdonato M, Di Vieste G . One-year effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome. Climacteric. 2011; 15(5):490-5. DOI: 10.3109/13697137.2011.631063. View

Carlomagno G, Unfer V . Inositol safety: clinical evidences. Eur Rev Med Pharmacol Sci. 2011; 15(8):931-6. View

Salehpour S, Nazari L, Hoseini S, Saharkhiz N, Ghazi F, Reza Sohrabi M . A Potential Therapeutic Role of Myoinositol in the Metabolic and Cardiovascular Profile of PCOS Iranian Women Aged between 30 and 40 Years. Int J Endocrinol. 2016; 2016:7493147. PMC: 5014950. DOI: 10.1155/2016/7493147. View

Unfer V, Raffone E, Rizzo P, Buffo S . Effect of a supplementation with myo-inositol plus melatonin on oocyte quality in women who failed to conceive in previous in vitro fertilization cycles for poor oocyte quality: a prospective, longitudinal, cohort study. Gynecol Endocrinol. 2011; 27(11):857-61. DOI: 10.3109/09513590.2011.564687. View

10.

Corrado F, DAnna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A . The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med. 2011; 28(8):972-5. DOI: 10.1111/j.1464-5491.2011.03284.x. View

11.

Bevilacqua A, Bizzarri M . Inositols in Insulin Signaling and Glucose Metabolism. Int J Endocrinol. 2019; 2018:1968450. PMC: 6286734. DOI: 10.1155/2018/1968450. View

12.

Croze M, Vella R, Pillon N, Soula H, Hadji L, Guichardant M . Chronic treatment with myo-inositol reduces white adipose tissue accretion and improves insulin sensitivity in female mice. J Nutr Biochem. 2012; 24(2):457-66. DOI: 10.1016/j.jnutbio.2012.01.008. View

13.

Saltiel A . Second messengers of insulin action. Diabetes Care. 1990; 13(3):244-56. DOI: 10.2337/diacare.13.3.244. View

14.

Giordano D, Corrado F, Santamaria A, Quattrone S, Pintaudi B, Di Benedetto A . Effects of myo-inositol supplementation in postmenopausal women with metabolic syndrome: a perspective, randomized, placebo-controlled study. Menopause. 2010; 18(1):102-4. DOI: 10.1097/gme.0b013e3181e8e1b1. View

15.

Unfer V, Facchinetti F, Orru B, Giordani B, Nestler J . Myo-inositol effects in women with PCOS: a meta-analysis of randomized controlled trials. Endocr Connect. 2017; 6(8):647-658. PMC: 5655679. DOI: 10.1530/EC-17-0243. View

16.

Genazzani A, Lanzoni C, Ricchieri F, Jasonni V . Myo-inositol administration positively affects hyperinsulinemia and hormonal parameters in overweight patients with polycystic ovary syndrome. Gynecol Endocrinol. 2008; 24(3):139-44. DOI: 10.1080/09513590801893232. View

17.

Clements Jr R, Darnell B . Myo-inositol content of common foods: development of a high-myo-inositol diet. Am J Clin Nutr. 1980; 33(9):1954-67. DOI: 10.1093/ajcn/33.9.1954. View

18.

Whiteman E, Cho H, Birnbaum M . Role of Akt/protein kinase B in metabolism. Trends Endocrinol Metab. 2002; 13(10):444-51. DOI: 10.1016/s1043-2760(02)00662-8. View

19.

Holub B . The nutritional importance of inositol and the phosphoinositides. N Engl J Med. 1992; 326(19):1285-7. DOI: 10.1056/NEJM199205073261909. View

20.

Banuls C, Rovira-Llopis S, Falcon R, Veses S, Monzo N, Victor V . Chronic consumption of an inositol-enriched carob extract improves postprandial glycaemia and insulin sensitivity in healthy subjects: A randomized controlled trial. Clin Nutr. 2015; 35(3):600-7. DOI: 10.1016/j.clnu.2015.05.005. View